期刊文献+

李光荣教授治疗多囊卵巢综合征规律研究 被引量:2

Research on the Treatment Regularity of Professor Li Guang-rong Treating Polycystic Ovary Syndrome
下载PDF
导出
摘要 目的研究李光荣教授治疗多囊卵巢综合征(PCOS)的治疗规律。方法将李教授诊治的PCOS患者共54例638诊次的病历采用结构化病历模板录入数据库,用名老中医临床诊疗信息采集系统软件对数据进行统计分析。结果李教授应用频次高的治法有补肾、活血、调肝、健脾等;应用频次高的基本方有自拟补肾汤、泽兰汤、逍遥散、六味地黄丸、苍附导痰汤等;应用频次高的药物有当归、白芍、淫羊藿、益母草、柴胡等19味药;应用药物种类最多的是补肾药,其次为调肝药、活血药、健脾药。结论李教授治疗PCOS注重顾护阴血和补肾、调肝、健脾,治疗以补肾活血为基础,强调情志因素的致病作用。 Objective To research the treatment regularity of professor Li Guang-rong treating polycystic ovay syndrome (PCOS). Method Medical records of 54 PCOS patients treated by Professor Li for 638 consultations were input into database by structuralized medical history template. Systematically analyze the data with the System Software of OLD TCM Clinical Diagnosis and Treatment Information Collection. Results The treatment principle involving supplement kidney, invigorate blood, adjust liver, fortify spleen is comparatively frequently used; formulations including Decoction of self-prepared strengthening kidney, Decoction of Herba Lycopi, Ease Powder, Six-Ingredient Rehmannia Pill, Decoction of Atractylodes and Cyperus Expelling Phlegm are comparatively frequently used; 19 herbal medicines are comparatively frequently used. The most frequently used medicine sort is supplement kidney medicine, followed by medicine of adjust liver, invigorate blood and fortify spleen. Conclusion Professor Li pays more attention to protecting yin-blood, supplementing kidney, adjusting liver and fortifing spleen in treating PCOS. The treatment is based on supplementing kidney and invigorating blood. The emotion factor should be emphasized.
出处 《中国中医药信息杂志》 CAS CSCD 2011年第4期20-22,共3页 Chinese Journal of Information on Traditional Chinese Medicine
基金 北京市科技计划重大项目(D08050703020803) 中国中医科学院第三批优势病种项目(CACMS08Y006) 广安门医院2007年所级课题(2007s105)
关键词 名老中医 李光荣 多囊卵巢综合征 治疗规律 old doctor ofTCM LI guang-rong polycystic ovary syndrome treatment regularity
  • 相关文献

参考文献3

二级参考文献14

  • 1Yen SSC.Polycystic ovary syndrome reproductive endocrinology.4th ed,Philadelphia,WB Saunders,1999.436-478.
  • 2Sharpless JL.Polycystic ovary syndrome and the metabolic syndrome.Clin Diab,2003,21:154-161.
  • 3Richardson MR.Current perspectives in polycystic ovary syndrome.Am Fam Physician,2003,68:697-704.
  • 4Goumenou AG,Matalliotakis IM,Koumantakis GE,et al.The role of leptin in fertility.Eur J Obstet Gynecol Reprod Biol,2003,106:118-124.
  • 5The Rotterdam ESHRE/ASRM-Sponsored PCOS Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.Fertil Steril,2004,81:19-25.
  • 6Lord JM,Flight IH,Norman RJ.Metformin in polycystic ovary syndrome: systematic review and meta-analysis.BMJ,2003,327:951-953.
  • 7Coffey S, Mason H. The effect of polycystic ovary syndrom on health related quality of life. Gynecol Endocrinol,2003;17(5):379~86.
  • 8Elsenbruch S, Hahn S, Kowalsky D et al. Quality of life psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab,2003;88(12):5801~7.
  • 9Eggers S, Kirchengast S. The polycystic ovary syndrome a medical condition but also an important psychosocial problem. Coll Antropol, 2001; 25(2):673~85.
  • 10Pellieux C, Sauthier T, Domenighetti A et al. Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in pprimary cardiomyocytes via NPY Y5 receptors.Proc Natl Acad Sci USA, 2000;97(4):1595~600.

共引文献61

同被引文献38

  • 1朱许萍,李艳瑜,许岚.肠道菌群与多囊卵巢综合征代谢异常关系研究进展[J].南京医科大学学报(自然科学版),2020,40(12):1885-1889. 被引量:8
  • 2张义军,康白,耿秀芳,钟桂美.泽兰的降血脂作用研究[J].潍坊医学院学报,1993,15(1):16-17. 被引量:14
  • 3湖南省中医药学会组织编写,王净净,龙俊杰主编.中医临床病证诊断疗效标准(M)湖南科学技术出版社, 1993
  • 4The Rotterdam ESHRE/ASRM-sponsorde PCOS Consensus Workshop Group.Revised2003consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS. Human Reproduction . 2004
  • 5Wendy A. March,Vivienne M. Moore,Kristyn J. Willson.The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction . 2010
  • 6Xiaomiao Zhao,Renmin Ni,Lin Li,Yaqin Mo,Jia Huang,Meifeng Huang,Ricardo Azziz,Dongzi Yang.??Defining hirsutism in Chinese women: a cross-sectional study(J)Fertility and Sterility . 2011 (3)
  • 7Bulent Okan Yildiz,Gurkan Bozdag,Zuhal Yapici,Ibrahim Esinler,Hakan Yarali.??Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria(J)Human Reproduction . 2012 (10)
  • 8聂波,黄锋,刘勇,杜冠华,梁鑫淼,肖培根.泽兰抗氧化活性的研究及活性部位的筛选[J].中国中药杂志,2010,35(13):1754-1757. 被引量:10
  • 9冯文进,郝小金,王平乐,郝华,董秋梅.补肾活血“对药”对兔模型血液流变学影响的研究[J].北京中医药,2010,29(6):456-458. 被引量:4
  • 10本刊编辑部.朱南荪治疗闭经经验[J].中国社区医师,2010,26(25):19-19. 被引量:1

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部